| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
7,347 |
5,714 |
$188K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,084 |
3,623 |
$124K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,655 |
2,289 |
$116K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,128 |
1,894 |
$100K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
940 |
853 |
$66K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,825 |
2,437 |
$47K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
699 |
630 |
$6K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
395 |
209 |
$6K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
236 |
176 |
$6K |
| 99205 |
Prolong outpt/office vis |
15 |
15 |
$2K |
| 0012A |
|
14 |
14 |
$444.96 |
| 87807 |
|
16 |
12 |
$128.38 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
17 |
14 |
$22.50 |
| 99000 |
|
55 |
50 |
$0.00 |
| 91301 |
|
32 |
25 |
$0.00 |